<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100724'>Thrombophilia</z:hpo> is the term now used to describe predisposition to increased risk of venous and occasionally arterial <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> due to <z:hpo ids='HP_0001871'>hematological abnormalities</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It can be a multifactorial disorder where congenital defects of <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> or procoagulant factors may be combined with acquired <z:hpo ids='HP_0001871'>hematological abnormalities</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>It should be considered in patients with a documented unexplained thrombotic episode or a positive family history </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this document is to provide guidelines for investigation and management of patients with <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in the presence or absence of venous <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> (VTE) </plain></SENT>
</text></document>